Back

Predictors of serious complications during and immediately after catheter ablation of atrial fibrillation in 8302 procedures: J-CARAF Study

18 June 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Moderated Poster session 5 - Treatment strategies and ablation outcome Catheter ablation (Atrial Fibrillation) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Professor Yuji Murakawa

Mizonokuchi Hospital- Teikyo University School of Medicine, Kawasaki (Japan)

7 More presentations in this session

Presentation thumbnail
Efficacy of non-vitamin k antagonist oral anticoagulants for perioperative complication in patients with atrial fibrillation undergoing catheter ablation.
Doctor T. Iseda (Wakayama, JP)
Abstract
Presentation thumbnail
Is the transesophageal echocardiography mandatory in patients undergoing atrial fibrillation ablation with uninterrupted novel anticoagulants?
Doctor A. Shapieva (Cottbus, DE)
Abstract Slides
Presentation thumbnail
The incidence of complications in the setting of second-generation cryoballoon ablation of atrial fibrillation: a comparison between vitamin K antagonists and novel oral anticoagulants
Presentation thumbnail
Long-term outcomes of supraventricular tachycardia ablation in congenital heart disease: single centre uk experience
Doctor V. Sawhney (London, GB)
Abstract
Presentation thumbnail
Long-term outcomes after catheter ablation of ventricular tachycardia in patients with structural heart disease: a Multicentre UK Study
Doctor A. Breitenstein (Zurich, CH)
Abstract

Access the full session

Session thumbnail
Moderated Poster session 5 - Treatment strategies and ablation outcome

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources